int-palladium-testing-system.02.png

Leadership

    Integrated Nano-Technologies

    Founded in 2000 by an interdisciplinary team of scientists and engineers, INT has addressed not only the technological barriers of streamlining such complex and diverse processes into a portable platform, but has approached it with the input and support of its target customers, governmental agencies, and global foundations.
    D. MICHAEL CONNOLLY, PHD
    CEO
    Michael is the Chairman of the Board. He is also President and Chief Executive Officer of the Company. He has a PhD in molecular biology from Northwestern University and completed a post-doctoral fellowship in the Department of Microbiology at the University of Illinois Medical Center. After completing his JD at Cornell University, he practiced as a patent attorney at Nixon Peabody, LLP in Rochester. While at Nixon Peabody, he played a significant role in developing the licensing strategy for a major genetic sequencing enterprise, as well as patenting and licensing technologies for several other companies and universities.
    Stay in the know on INT technology!
    Get started here!
    INT is committed to providing fast, accurate test results that improve biological identification in the field and in operating facilities such as food processing plants. Founded in 2000 by an interdisciplinary team of scientists and engineers, INT has developed a robust platform, Palladium™, for diagnostics and sample processing, replacing traditionally time-sensitive and complex lab processes.

    Applications

    Subscribe To Our Newsletter

    RESOURCES

    © Copyright 2018 | All Rights Reserved